Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Cell Reports
|
August 16, 2018
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Ryan Raisner, Samir Kharbanda, Lingyan Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2015
An Antibody-Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies
Jyoti Asundi, Lisa Crocker, Jarrod Tremayne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Suppression of HER2/HER3-mediated growth of breast cancer cells with combinations of GDC-0941 PI3K inhibitor, trastuzumab, and pertuzumab
Evelyn Yao, Wei Zhou, Si Tuen Lee-Hoeflich, et al.
Molecular Cancer Research : MCR
|
April 18, 2009
Genetic alterations and oncogenic pathways associated with breast cancer subtypes
Xiaolan Hu, Howard M Stern, Lin Ge, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 23, 2018
Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration
Yoong Wearn Lim, Haiyin Chen-Harris, Oleg Mayba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors
David S Shames, Kristi Elkins, Kimberly Walter, et al.
Cancer Research
|
April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes
Genee Y Lee, Peter M Haverty, Li Li, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|
December 4, 2013
Integrative analysis of two cell lines derived from a non-small-lung cancer patient--a panomics approach
Oleg Mayba, Florian Gnad, Michael Peyton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
Christy C Ong, Adrian M Jubb, Peter M Haverty, et al.
Nature Communications
|
November 21, 2019
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
Yu Kong, Christopher M Rose, Ashley A Cass, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Cell Reports
|
August 16, 2018
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Ryan Raisner, Samir Kharbanda, Lingyan Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2015
An Antibody-Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies
Jyoti Asundi, Lisa Crocker, Jarrod Tremayne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Suppression of HER2/HER3-mediated growth of breast cancer cells with combinations of GDC-0941 PI3K inhibitor, trastuzumab, and pertuzumab
Evelyn Yao, Wei Zhou, Si Tuen Lee-Hoeflich, et al.
Molecular Cancer Research : MCR
|
April 18, 2009
Genetic alterations and oncogenic pathways associated with breast cancer subtypes
Xiaolan Hu, Howard M Stern, Lin Ge, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 23, 2018
Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration
Yoong Wearn Lim, Haiyin Chen-Harris, Oleg Mayba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors
David S Shames, Kristi Elkins, Kimberly Walter, et al.
Cancer Research
|
April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes
Genee Y Lee, Peter M Haverty, Li Li, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|
December 4, 2013
Integrative analysis of two cell lines derived from a non-small-lung cancer patient--a panomics approach
Oleg Mayba, Florian Gnad, Michael Peyton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
Christy C Ong, Adrian M Jubb, Peter M Haverty, et al.
Nature Communications
|
November 21, 2019
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
Yu Kong, Christopher M Rose, Ashley A Cass, et al.
Page
of 6